Colin Larkworthy

Former CTSO

Jenner Institute, University of Oxford, United Kingdom (UK)

Email: colin.larkworthy@gmail.com  

VALIDATE Role:

Network Affiliate

Research area keywords:

Clinical Trials

Key publications:

• Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses, Folegatti, P et al (2020) – part of the Oxford Vaccine Centre Team.
• Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trials - Maheshi N Ramasamy et al (2020) – Part of the Oxford Vaccine Centre Team